文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年慢病共病管理

DNA甲基化变异性提供衰老异质性的补充表观遗传特征

DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2026-01-01

该研究在加拿大老龄化纵向研究1445名45至85岁参与者血样中,进行全表观基因组差异甲基化和方差关联分析,识别出448个差异甲基化区域和488个差异变异区域,二者重叠极少。整合两类显著CpG构建的表观遗传生物标志物与全因死亡率相关,区分度高于单独使用任一分析,并在巴尔的摩老龄化纵向研究中重现类似模式。

要点

  • 差异甲基化区域和差异变异区域仅少量重叠,基因覆盖不同,提示变异性提供互补信号。
  • 差异甲基化区域富集免疫和炎症通路,差异变异区域富集CpG岛相关局部信号。
  • 整合两类CpG的生物标志物与全因死亡率相关,区分度优于单独分析。

核心结论

  • DNA甲基化变异性可能提供表观遗传衰老的补充维度。
  • 整合差异甲基化和差异变异信号的生物标志物与全因死亡率相关且区分度更高。

研究设计与样本

  • 研究纳入加拿大老龄化纵向研究1445名45至85岁加拿大参与者,采集血样进行全表观基因组差异甲基化和方差关联分析。
  • 在巴尔的摩老龄化纵向研究中对生物标志物模式进行重现验证。

主要发现

  • 识别出448个差异甲基化区域和488个差异变异区域,与健康衰退(以健康缺陷累积衰弱指数、认知功能和躯体功能衡量)相关。
  • 两类区域重叠极少,基因覆盖不同,提示变异性贡献互补信号。
  • 差异甲基化区域覆盖基因富集免疫和炎症相关通路。
  • 差异变异区域突出额外的局部、CpG岛富集信号,跨健康域共享。
  • 整合两类显著CpG构建的表观遗传生物标志物与全因死亡率相关,区分度高于单独基于差异甲基化或变异性的标志物。

局限性

  • 作者建议需在更大队列和更多死亡事件中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human aging does not follow a single trajectory. Epigenetic changes offer insight into the heterogeneity in aging by reflecting the combined influence of genetic, environmental, and lifestyle factors on the timing and progression of age-related changes beyond what chronological age alone can explain. Recent studies in cancer and aging underscore the importance of methylation variability as a marker of biological dysregulation. METHODS: We investigated the role of DNA methylation in aging heterogeneity by performing epigenome-wide differential methylation and variance association analyses in blood samples from 1445 Canadians aged 45 to 85 from the Canadian Longitudinal Study on Aging. RESULTS: We identified 448 differentially methylated regions and 488 differentially variable regions associated with health decline as measured by the health deficit accumulation frailty index, cognitive function, and physical function. These two classes of regions showed minimal overlap, with distinct gene coverage, suggesting that variability contributes a complementary signal to aging heterogeneity. Genes overlapped by differentially methylated regions were enriched for immune and inflammation-related pathways, whereas differentially variable regions highlighted additional localized, CpG‑island-enriched signals shared across health domains, consistent with regionally structured rather than diffuse dysregulation. By integrating significant CpGs from both analyses, we constructed an epigenetic biomarker. The biomarker was associated with all-cause mortality and showed higher discrimination than biomarkers constructed from differential methylation or variability alone, with a similar pattern reproduced in the Baltimore Longitudinal Study of Aging. CONCLUSIONS: These findings suggest that DNA methylation variability may provide a complementary dimension of epigenetic aging and support further evaluation in larger cohorts with more mortality events.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Vishnyakova O, Min J, Moore AZ, et al. DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42755069. doi:10.1093/gerona/glag234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。